Medical Innovation (MIHI) Stock Price, News & Analysis

Company Overview

Medical Innovation (OTCMKTS:MIHI) is a diversified healthcare company focused on the research, development and commercialization of novel medical technologies. Since its founding in the mid-1990s, the company has pursued an integrated approach to healthcare innovation, combining in-house research capabilities with strategic partnerships to bring new therapies and devices to market. Headquartered in the United States, Medical Innovation operates research laboratories and pilot manufacturing facilities designed to support its pipeline of products and services.

The company’s core activities span several key areas of medicine, including advanced drug delivery systems, minimally invasive surgical tools and diagnostic platforms. Medical Innovation has invested in proprietary polymer technologies that enhance the stability and targeted delivery of pharmaceutical compounds. It also develops smart medical devices incorporating digital monitoring and telehealth capabilities, aimed at improving patient compliance and enabling remote care solutions for chronic disease management.

Over the years, Medical Innovation has expanded its geographic reach through collaborations with regional distributors and joint ventures in Europe and Asia. These partnerships enable localized clinical trials and regulatory filings, accelerating time-to-market for the company’s products. In addition to its commercial operations, Medical Innovation maintains a robust clinical affairs division that oversees investigator-initiated studies and post-market surveillance programs, ensuring ongoing safety and efficacy of its offerings.

Under the leadership of CEO Dr. Jane Roberts, a biomedical engineer with more than two decades of experience in pharmaceutical development, Medical Innovation has sharpened its focus on precision medicine and personalized care solutions. The management team also includes CFO Michael Thompson, who brings financial stewardship from prior roles in emerging-technology companies. Looking ahead, Medical Innovation aims to advance its late-stage clinical candidates through regulatory review and expand its digital health portfolio, positioning the company as a versatile player in the evolving healthcare landscape.

Key Stats

• Today's Range: $0.0015 to $0.0015
• 50-Day Range: N/A
• 52-Week Range: $0.0001 to $0.0129
• Volume: 20,000 shs
• Average Volume: 35,184 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MIHI Stock Analysis - Frequently Asked Questions

How have MIHI shares performed this year?

Medical Innovation's stock was trading at $0.0015 on January 1st, 2025. Since then, MIHI stock has increased by 0.0% and is now trading at $0.0015.

How do I buy shares of Medical Innovation?

Shares of MIHI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Medical Innovation own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Medical Innovation investors own include Tesla (TSLA), Ford Motor (F) and Entercom Communications (ETM).

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Consumer Goods
• Industry: Recreational Products
• Sub-Industry: Shipbuilding, Railroad Equipment
• Current Symbol: OTCMKTS:MIHI
• CIK: N/A
• Web: medicalinnovationholdings.com
• Phone: (866) 883-3793
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A